D. A. Stopher

652 total citations
18 papers, 563 citations indexed

About

D. A. Stopher is a scholar working on Pharmacology, Analytical Chemistry and Oncology. According to data from OpenAlex, D. A. Stopher has authored 18 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Analytical Chemistry and 7 papers in Oncology. Recurrent topics in D. A. Stopher's work include Analytical Methods in Pharmaceuticals (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). D. A. Stopher is often cited by papers focused on Analytical Methods in Pharmaceuticals (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). D. A. Stopher collaborates with scholars based in United Kingdom and United States. D. A. Stopher's co-authors include P. V. Macrae, Alan Beresford, Michael Humphrey, B. Kaye, Brian Wood, J. K. Faulkner, Dennis A. Smith, Don K. Walker, JL Reid and N. J. CUSSANS and has published in prestigious journals such as Journal of the Science of Food and Agriculture, British Journal of Clinical Pharmacology and Journal of Pharmacy and Pharmacology.

In The Last Decade

D. A. Stopher

18 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. A. Stopher United Kingdom 10 170 140 128 125 124 18 563
Chii‐Ming Lai United States 14 106 0.6× 147 1.1× 107 0.8× 99 0.8× 116 0.9× 36 660
DB Jack United Kingdom 15 145 0.9× 105 0.8× 153 1.2× 70 0.6× 152 1.2× 40 609
Edward C. Conradi United States 13 180 1.1× 98 0.7× 164 1.3× 70 0.6× 211 1.7× 19 658
Richard A. Okerholm United States 18 129 0.8× 131 0.9× 170 1.3× 163 1.3× 193 1.6× 36 842
Gwyn H. Evans United States 11 174 1.0× 180 1.3× 205 1.6× 160 1.3× 226 1.8× 12 921
RG Shanks United Kingdom 12 146 0.9× 243 1.7× 106 0.8× 124 1.0× 78 0.6× 39 592
Richard H. Reuning United States 15 143 0.8× 102 0.7× 133 1.0× 146 1.2× 107 0.9× 45 809
Sandra R. Harapat United States 16 215 1.3× 258 1.8× 170 1.3× 115 0.9× 101 0.8× 18 862
Renpei Nagashima United States 11 101 0.6× 87 0.6× 136 1.1× 204 1.6× 203 1.6× 15 721
Linyee Shum United States 12 127 0.7× 186 1.3× 91 0.7× 271 2.2× 101 0.8× 23 782

Countries citing papers authored by D. A. Stopher

Since Specialization
Citations

This map shows the geographic impact of D. A. Stopher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Stopher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Stopher more than expected).

Fields of papers citing papers by D. A. Stopher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. Stopher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Stopher. The network helps show where D. A. Stopher may publish in the future.

Co-authorship network of co-authors of D. A. Stopher

This figure shows the co-authorship network connecting the top 25 collaborators of D. A. Stopher. A scholar is included among the top collaborators of D. A. Stopher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. Stopher. D. A. Stopher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Walker, Don K., Kevin Beaumont, D. A. Stopher, & Dennis A. Smith. (1996). Pharmacokinetics of a series of bis(methanesulphonamido-arylalkyl)amines in the beagle dog. Xenobiotica. 26(10). 1101–1111. 5 indexed citations
2.
Smith, Dennis A., et al.. (1992). Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man. Xenobiotica. 22(6). 709–719. 55 indexed citations
3.
Kaye, B., et al.. (1992). The sensitive determination of abanoquil in blood by high-performance liquid chromatography/atmospheric pressure ionization mass spectrometry. Journal of Mass Spectrometry. 21(11). 585–589. 38 indexed citations
4.
Smith, Dennis A., N. J. CUSSANS, Michael Humphrey, et al.. (1992). Bioanalytical data in decision making: Discovery and development. Xenobiotica. 22(9-10). 1195–1205. 5 indexed citations
5.
Walker, Don K., G. Wynne Aherne, John Arrowsmith, et al.. (1991). Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay. Journal of Pharmaceutical and Biomedical Analysis. 9(2). 141–149. 25 indexed citations
6.
Walker, Don K., Dennis A. Smith, & D. A. Stopher. (1991). Liquid—liquid extraction and high-performance liquid chromatography for the determination of a novel antidysrhythmic agent (UK-68,798) in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 568(2). 475–480. 6 indexed citations
7.
Beresford, Alan, P. V. Macrae, & D. A. Stopher. (1988). Metabolism of amlodipine in the rat and the dog: A species difference. Xenobiotica. 18(2). 169–182. 30 indexed citations
8.
Beresford, Alan, et al.. (1988). Metabolism and kinetics of amlodipine in man. Xenobiotica. 18(2). 245–254. 68 indexed citations
9.
Stopher, D. A., Alan Beresford, P. V. Macrae, & Michael Humphrey. (1988). The Metabolism and Pharmacokinetics of Amlodipine in Humans and Animals. Journal of Cardiovascular Pharmacology. 12(Supplement 7). S55–S59. 139 indexed citations
10.
Beresford, Alan, P. V. Macrae, D. A. Stopher, & Brian Wood. (1987). Analysis of amlodipine in human plasma by gas chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 420(1). 178–183. 77 indexed citations
11.
Kaye, B., et al.. (1986). The metabolism and kinetics of doxazosin in man, mouse, rat and dog.. British Journal of Clinical Pharmacology. 21(S1). 19S–25S. 69 indexed citations
12.
Stopher, D. A., et al.. (1981). Isolation, characterization and direct estimation of dazoxiben and its glucuronide from human plasma and urine. Xenobiotica. 11(12). 849–856. 3 indexed citations
13.
Faulkner, J. K., D. A. Stopher, Roderick Walden, William Singleton, & S. H. Taylor. (1976). Bioavailability of tolamolol. European Journal of Clinical Pharmacology. 9(4). 315–317. 1 indexed citations
14.
Stopher, D. A.. (1975). Thin layer chromatography – fluorimetrie estimation of tolamolol in human plasma. Journal of Pharmacy and Pharmacology. 27(2). 133–134. 5 indexed citations
15.
Wood, Brian, D. A. Stopher, & A. M. Monro. (1975). The Metabolism of Tolamolol* in the Mouse, Rat, Guinea-pig, Rabbit and Dog. Xenobiotica. 5(3). 183–195. 5 indexed citations
16.
Faulkner, J. K., D. A. Stopher, & Roderick Walden. (1975). Pharmacokinetic and pharmacological studies with tolamolol in man.. British Journal of Clinical Pharmacology. 2(5). 423–428. 13 indexed citations
17.
Faulkner, J. K. & D. A. Stopher. (1972). The Metabolism of N-(3-Chlorobenzenesulphonyl) acetamidine in the Dog and Rat. Xenobiotica. 2(2). 179–189. 2 indexed citations
18.
Faulkner, J. K., S. K. Figdor, A. M. Monro, et al.. (1972). The comparative metabolism of pyrantel in five species. Journal of the Science of Food and Agriculture. 23(1). 79–91. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026